tirzepatide and fasting Day 3: Mounjaro (Tirzepatide – weekly injection) Class: Dual GLP-1 GIP receptor agonist Avg Weight Loss: ~20% of baseline weight (SURMOUNT-1 trial) FDA Status: Approved for type 2 diabetes; Fast-tracked for Yurpeak (Tirzepatide) in India: A
Pay in 4 interest-free payments of $6.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




















![Forest (294) [Alpha Edition] Wizard Otter](https://cdn.shopify.com/s/files/1/0898/0181/8406/files/6d0837ed-938c-518f-ad12-8ac0394c5b7d.jpg?v=1742013071)


